hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06354205, orgStudyIdInfo id: 24-3.1T/98, briefTitle: Comparison of Salivary Procalcitonin (PCT) Levels and Serum PCT Levels, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-06-01, primaryCompletionDateStruct date: 2025-03-01, completionDateStruct date: 2025-04-01, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Ege University, class: OTHER, collaborators name: THE SCIENTIFIC AND TECHNOLOGICAL RESEARCH COUNCIL OF TÜRKİYE, descriptionModule briefSummary: Recently, it has been seen that investigations from saliva samples could be an alternative to those from blood samples. Saliva collection is a simple, non-invasive, cost-effective, and relatively easy method, making it potentially suitable as a new diagnostic tool in pediatric patients. In the current literature, elevated levels of saliva CRP, TNF-α, IL-6, and IFN-γ have been reported in inflammatory conditions. However, while there are animal studies suggesting the use of saliva PCT levels for focal diseases such as gingival inflammation and periodontitis and as a potential tool for non-invasive detection of sepsis, there is no human study regarding its use in systemic infections.The aim of this study is to evaluate the correlation between serum PCT levels and saliva PCT levels in children suspected of SBE and to determine the diagnostic value of saliva PCT., conditionsModule conditions: Bacterial Infections, conditions: Children, Only, conditions: Procalcitonin, conditions: Saliva, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: DIAGNOSTIC, maskingInfo masking: NONE, enrollmentInfo count: 160, type: ESTIMATED, armsInterventionsModule interventions name: Sliva Procalcitonin, outcomesModule primaryOutcomes measure: Correlation, secondaryOutcomes measure: Diagnose, eligibilityModule sex: ALL, minimumAge: 0 Years, maximumAge: 1 Year, stdAges: CHILD, contactsLocationsModule locations facility: Ege University School of Medicine, status: RECRUITING, city: İzmir, zip: 35100, country: Turkey, contacts name: Caner Turan, role: CONTACT, geoPoint lat: 38.41273, lon: 27.13838, hasResults: False
protocolSection identificationModule nctId: NCT06354192, orgStudyIdInfo id: 0450, briefTitle: Precision Nudging for Hypertension Management: Observational Study, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-11, primaryCompletionDateStruct date: 2025-10-11, completionDateStruct date: 2026-10-11, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Lirio, class: INDUSTRY, collaborators name: Cone Health, descriptionModule briefSummary: The purpose of the proposed observational study is to explore the relations between data-driven personalization and equitable health outcomes in a digital health intervention (DHI) for hypertension management. In the current intervention, behavioral reinforcement learning is applied to personalize intervention content to maximize the behavioral outcomes of three target behaviors critical for effective hypertension management: clinical encounters, medication adherence, and self-monitoring of blood pressure (SMBP)., conditionsModule conditions: Hypertension, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 12000, type: ESTIMATED, armsInterventionsModule interventions name: Precision Nudging for Hypertension Management, outcomesModule primaryOutcomes measure: Clinical encounter behavioral outcome, primaryOutcomes measure: Blood pressure reading clinical outcome, secondaryOutcomes measure: Engagement, secondaryOutcomes measure: Medication adherence behavioral outcome, secondaryOutcomes measure: Self-monitoring of blood pressure behavioral outcome, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06354166, orgStudyIdInfo id: 2023-A02745-40, briefTitle: Study Human Digital Support Transitional Care, acronym: SUNH-ST, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2025-03, completionDateStruct date: 2025-03, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Divoluci, class: OTHER, descriptionModule briefSummary: The purpose of the study is to compare the effectiveness of Divomed in organising complex hospital discharges with a conventional organisation. Effectiveness will be assessed by reducing the length of stay of patients in geriatric short-stay care., conditionsModule conditions: Aging, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Interventional, randomised (1:1 ratio), single-centre study, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, maskingDescription: open-label study, enrollmentInfo count: 150, type: ESTIMATED, armsInterventionsModule interventions name: Unscheduled hospital admissions, outcomesModule primaryOutcomes measure: length of stay, eligibilityModule sex: ALL, minimumAge: 75 Years, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: CHRU de Tours - Hôpital Bretonneau, city: Tours, zip: 37044, country: France, contacts name: Wassim GANA, MD, role: CONTACT, email: w.gana@chu-tours.fr, geoPoint lat: 47.38333, lon: 0.68333, hasResults: False
protocolSection identificationModule nctId: NCT06354153, orgStudyIdInfo id: 0305898, briefTitle: Polarity Management Training Program for First Line Nurse Manager, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-12-01, primaryCompletionDateStruct date: 2023-04-30, completionDateStruct date: 2023-04-30, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Matrouh University, class: OTHER, descriptionModule briefSummary: Polarities are vital issues in healthcare systems. Nursing is a profession riddled with polarities. If first-line nurse managers are well trained to manage polarities in the workplace, this could lead to positive outcomes for nurses, nurse managers and organization performance., conditionsModule conditions: Intervention, conditions: Knowledge, Attitudes, Practice, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: SINGLE_GROUP, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: SINGLE, maskingDescription: A quasi-experimental design utilized one group for pre-, post, and follow-up intervention., whoMasked: PARTICIPANT, enrollmentInfo count: 60, type: ACTUAL, armsInterventionsModule interventions name: Polarity Management Training Program, outcomesModule primaryOutcomes measure: Questionnaire to measure nurse managers' knowledge, primaryOutcomes measure: Nursing polarity case study situations to assess first-line nurse manager's ability to differentiate between problems to solve and polarities to manage, primaryOutcomes measure: Questionnaire to measure creativity behavior of first-line nurse managers, primaryOutcomes measure: questionnaire to measure intrinsic work motivation among first-line nurse managers, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Faculty of Nursing, Matrouh University, city: Marsa Matruh, zip: 002, country: Egypt, geoPoint lat: 31.3529, lon: 27.23725, hasResults: False
protocolSection identificationModule nctId: NCT06354140, orgStudyIdInfo id: WeGuo, briefTitle: PPIO-008S-1 Combined With Tislelizumab in Patients With Primary Residual Node-negative Esophageal Squamous Cell Carcinoma (ESCC) After Radical Resection With Neoadjuvant Immunotherapy Combined With Chemotherapy, PHASE II STUDY, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-07, primaryCompletionDateStruct date: 2027-04-30, completionDateStruct date: 2028-04-30, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, class: OTHER, descriptionModule briefSummary: To explore the safety and efficacy of Tegafur combined with tislelizumab in patients with esophageal squamous cell carcinoma with residual primary lesion and node-negative after radical resection following neoadjuvant immunotherapy combined with chemotherapy, conditionsModule conditions: Postoperative Assistance for Esophageal Squamous Cell Carcinoma With Negative Lymph Nodes, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, maskingDescription: The study was a one-arm open study, enrollmentInfo count: 45, type: ESTIMATED, armsInterventionsModule interventions name: Tegafur, outcomesModule primaryOutcomes measure: 1-year DFS rate, secondaryOutcomes measure: Overall survival, secondaryOutcomes measure: Progression-free survival, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Army Medical Center of the People's Liberation Army, status: RECRUITING, city: Chongqing, state: Chongqing, zip: 400042, country: China, contacts name: Guo, role: CONTACT, phone: +8613527323568, email: gyguowei@hotmail.com, geoPoint lat: 29.56278, lon: 106.55278, hasResults: False
protocolSection identificationModule nctId: NCT06354127, orgStudyIdInfo id: DW_DWP450009, briefTitle: DWP450 for Treating Moderate to Severe Glabellar Lines, statusModule overallStatus: COMPLETED, startDateStruct date: 2020-08-12, primaryCompletionDateStruct date: 2020-11-24, completionDateStruct date: 2021-01-25, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Daewoong Pharmaceutical Co. LTD., class: INDUSTRY, descriptionModule briefSummary: A multi-center, randomized, double-blind, positive drug-controlled clinical study to evaluate the safety and efficacy of Botulinum Toxin Type A for Injection in the treatment of moderate to severe glabellar lines, conditionsModule conditions: Moderate to Severe Glabellar Lines, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 473, type: ACTUAL, armsInterventionsModule interventions name: DWP450, interventions name: Botox®, outcomesModule primaryOutcomes measure: Response rate based on the investigator's on-site assessment of severity of glabellar lines at maximum frown, eligibilityModule sex: ALL, minimumAge: 20 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, city: Shanghai, state: Shanghai, country: China, geoPoint lat: 31.22222, lon: 121.45806, hasResults: False
protocolSection identificationModule nctId: NCT06354114, orgStudyIdInfo id: SYHX2011-003, briefTitle: A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2024-10-31, completionDateStruct date: 2026-12, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: CSPC Ouyi Pharmaceutical Co., Ltd., class: INDUSTRY, descriptionModule briefSummary: The main purpose of this study is to evaluate the efficacy and safety in subjects with advanced breast cancer treated with SYHX2011, conditionsModule conditions: Advanced Breast Cancer, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: SYHX2011, outcomesModule primaryOutcomes measure: Objective Response Rate (ORR) by Investigator, secondaryOutcomes measure: Progression-Free-Survival (PFS), secondaryOutcomes measure: Time to progression (TTP), secondaryOutcomes measure: Incidence of adverse events, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Harbin Medical University Cancer Hospital, city: Harbin, state: Heilongjiang, country: China, contacts name: Qingyuan Zhang, role: CONTACT, phone: 86-13313612989, email: 13313612989@163.com, geoPoint lat: 45.75, lon: 126.65, hasResults: False
protocolSection identificationModule nctId: NCT06354101, orgStudyIdInfo id: CorEvitas-VITALITY, briefTitle: The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study., statusModule overallStatus: WITHDRAWN, startDateStruct date: 2023-07-01, primaryCompletionDateStruct date: 2023-07-01, completionDateStruct date: 2023-07-01, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: CorEvitas, class: NETWORK, collaborators name: Eli Lilly and Company, descriptionModule briefSummary: The purpose of this registry study is to learn more about metabolic health. The information gathered will be used to support research on the natural history of obesity and weight related diseases, their treatments, and how it affects overall health. Approximately 15,000 participants who are overweight or have obesity with or without metabolic diseases are expected to participate in this registry study., conditionsModule conditions: Metabolic Health, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 0, type: ACTUAL, armsInterventionsModule interventions name: Tirzepatide, interventions name: Semaglutide, outcomesModule primaryOutcomes measure: Main Objective of Registry, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06354075, orgStudyIdInfo id: IRBN302024/CHUSTE, briefTitle: Evaluation of Patient Information in Interventional Radiology, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2026-03, completionDateStruct date: 2026-03, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Centre Hospitalier Universitaire de Saint Etienne, class: OTHER, descriptionModule briefSummary: Interventional radiology is developing. Patient information modalities are also evolving, in particular information videos., conditionsModule conditions: Patient Satisfaction, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 50, type: ESTIMATED, armsInterventionsModule interventions name: Questionary, outcomesModule primaryOutcomes measure: to evaluate satisfaction of patient of explanatory videos in interventional radiology, primaryOutcomes measure: To evaluate satisfaction of patient of comic book in interventional radiology, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Chu Saint-Etienne, status: RECRUITING, city: Saint-Étienne, zip: 42055, country: France, contacts name: Sylvain GRANGE, MD, role: PRINCIPAL_INVESTIGATOR, contacts name: Rémi GRANGE, MD, role: SUB_INVESTIGATOR, geoPoint lat: 45.43389, lon: 4.39, hasResults: False
protocolSection identificationModule nctId: NCT06354062, orgStudyIdInfo id: 0305896, briefTitle: Talent Management Intervention Program for First-Line Nurse Managers, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-12-01, primaryCompletionDateStruct date: 2023-04-30, completionDateStruct date: 2023-04-30, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Matrouh University, class: OTHER, descriptionModule briefSummary: Nurse leaders will be required to manage the rapid change in the healthcare system. Talent management training plays a crucial role in preparing nursing leaders and improving their performance in health care systems., conditionsModule conditions: Intervention, conditions: Behavior, conditions: Knowledge, Attitudes, Practice, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: SINGLE_GROUP, interventionModelDescription: A quasi-experimental design, primaryPurpose: OTHER, maskingInfo masking: SINGLE, maskingDescription: First Line Nurse Managers received talent Management intervention program, whoMasked: PARTICIPANT, enrollmentInfo count: 125, type: ACTUAL, armsInterventionsModule interventions name: Talent management intervention program, outcomesModule primaryOutcomes measure: Questionnaire to measure nurse managers' knowledge, primaryOutcomes measure: Questionnaire to measure talent management practice among first line nurse managers., primaryOutcomes measure: Questionnaire to measure first-line nurse manager job performance, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Faculty of Nursing, Matrouh University, city: Mersa Matruh, zip: 002, country: Egypt, geoPoint lat: 31.3529, lon: 27.23725, hasResults: False
protocolSection identificationModule nctId: NCT06354049, orgStudyIdInfo id: CASE3Z24, briefTitle: Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI), statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-30, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-03-31, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Case Comprehensive Cancer Center, class: OTHER, descriptionModule briefSummary: The purpose of this research is to investigate the delivery of Reiki to integrative oncology patients and assess its potential for improving cancer-related symptoms in this population., conditionsModule conditions: Cancer Pain, conditions: Oncology Pain, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: Reiki, outcomesModule primaryOutcomes measure: Recruitment rate as measured by the percentage of participants enrolled, primaryOutcomes measure: Retention rate as measured by the number of participants retained until the final survey point, primaryOutcomes measure: Attendance rate as measured by number of sessions attended per 6 sessions, primaryOutcomes measure: Protocol adherence rate as measured by the number of participants treated in manner consistent with the intervention, primaryOutcomes measure: Acceptability as measured by the patient mean of participant satisfaction survey, primaryOutcomes measure: Data completeness rate, secondaryOutcomes measure: Patient-reported outcomes as measured by PROMIS-29(Patient-Reported Outcomes Measurement Information System) score, secondaryOutcomes measure: Patient-reported outcomes as measured by ESAS(Edmonton Symptom Assessment System) scale, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 89 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, city: Cleveland, state: Ohio, zip: 44106, country: United States, geoPoint lat: 41.4995, lon: -81.69541, hasResults: False
protocolSection identificationModule nctId: NCT06354010, orgStudyIdInfo id: SENS-NH02, briefTitle: Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis, acronym: SONG, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2027-07, completionDateStruct date: 2027-07, studyFirstPostDateStruct date: 2024-04-09, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Sensorion, class: INDUSTRY, descriptionModule briefSummary: The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene., conditionsModule conditions: Sensorineural Hearing Loss, Bilateral, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: OTHER, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Genotyping, interventions name: Audiological assessments, outcomesModule primaryOutcomes measure: Evolution of hearing impairment of adult patients with early-onset presbycusis carrying mutations in GJB2 gene., primaryOutcomes measure: Evolution of hearing impairment of adult patients with early-onset presbycusis carrying mutations in GJB2 gene, secondaryOutcomes measure: Genetic characteristics of adult patients with early-onset presbycusis, secondaryOutcomes measure: Audiological characteristics of adult patients with early-onset presbycusis, secondaryOutcomes measure: Mood evaluation in adult patients with early-onset presbycusis carrying mutations in GJB2 gene, eligibilityModule sex: ALL, minimumAge: 30 Years, maximumAge: 55 Years, stdAges: ADULT, contactsLocationsModule locations facility: CHU Gui de Chauliac, city: Montpellier, zip: 34295, country: France, contacts name: Frederic Venail, Pr, role: CONTACT, geoPoint lat: 43.61092, lon: 3.87723, hasResults: False